Cargando…
Overview of Biomarkers and Surrogate Endpoints in Drug Development
There are numerous factors that recommend the use of biomarkers in drug development including the ability to provide a rational basis for selection of lead compounds, as an aid in determining or refining mechanism of action or pathophysiology, and the ability to work towards qualification and use of...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851644/ https://www.ncbi.nlm.nih.gov/pubmed/12364809 http://dx.doi.org/10.1155/2002/929274 |